Loading paragraph...
Today's Biggest Stock Losers
| Symbol | Name | Last Price | Change | % Change | Volume | Market Cap | 52-Week Range |
|---|---|---|---|---|---|---|---|
| ELAB | Pmgc | $6.16 | -$7.84 | -56.00% | 19.9M | $7.6M | $1.62$466.20 |
| EEIQ | EpicQuest Education Group International | $7.71 | -$2.87 | -27.13% | 590.4K | $16M | $1.90$27.84 |
| SST | System1 | $3.89 | -$1.33 | -25.48% | 2.3M | $42M | $1.35$15.00 |
| RENX | RenX Enterprises | $2.00 | -$0.62 | -23.56% | 1.3M | $6.1M | $1.42$47.20 |
| FGI | Fgi Industries | $4.04 | -$0.93 | -18.71% | 53.3K | $9.5M | $2.28$12.62 |
| CDT | Cdt Equity | $4.15 | -$0.95 | -18.63% | 113.6K | $902K | $4.08$4,200.00 |
| INBS | Intelligent Bio Solutions | $2.69 | -$0.43 | -13.78% | 1.1M | $6.2M | $2.56$24.90 |
| FTLF | FitLife Brands | $10.49 | -$1.61 | -13.31% | 34.1K | $114M | $9.83$20.98 |
| RVYL | Ryvyl | $5.06 | -$0.72 | -12.46% | 139.1K | $7.3M | $4.14$81.55 |
| ANGO | AngioDynamics | $10.50 | -$1.45 | -12.10% | 877.2K | $492M | $8.36$13.99 |
| YDDL | One And One Green Technologies. | $12.31 | -$1.69 | -12.07% | 502.9K | $756M | $3.61$15.90 |
| UGRO | Urban-gro | $19.35 | -$2.63 | -11.96% | 827.6K | $17M | $2.02$37.00 |
| LICN | Lichen International | $4.58 | -$0.61 | -11.75% | 124.4K | $85M | $2.57$8.28 |
| EKSO | Ekso Bionics | $9.50 | -$1.15 | -10.80% | 166.3K | $38M | $2.73$13.50 |
| ASTC | Astrotech | $4.00 | -$0.45 | -10.11% | 439K | $7.8M | $1.92$8.01 |
Related Articles
Featured Article
Should Growth Investors Buy This Revolutionary Small-Cap Stock?
Kody Kester|Jul 25, 2023
The medical devices company is taking an exciting approach to treating some of the most complex diseases.
Wall Street Thinks This Small-Cap Stock Can Double in Value
Kody Kester|Apr 4, 2023
Analysts are projecting a huge rebound from this beaten-down stock in the next 12 months.
Is This Under-the-Radar Growth Stock a Buy?
Kody Kester|Jan 19, 2023
This company is a small player in the steadily growing medtech industry.
Wall Street Thinks This Obscure Growth Stock Could Soar 92% in 2023
Kody Kester|Dec 30, 2022
As COVID-19 headwinds fade, AngioDynamics' business could rebound.
Here's Why This Hidden Growth Stock Is a Buy
Kody Kester|Oct 21, 2022
This medical device company may not be a household name, but it could be an up-and-comer.
Should You Buy This Under-the-Radar Growth Stock?
Kody Kester|Jul 29, 2022
Like the Nasdaq Composite, this little-known medical device stock has been beaten down in 2022.
3 Reasons to Consider Buying This Overlooked Medical Device Stock
Kody Kester|May 1, 2022
The Nasdaq's sell-off looks to have given investors a buying opportunity in this little-known medical device stock.
Is This Small-Cap Medical Devices Stock a Buy?
Kody Kester|Feb 1, 2022
AngioDynamics managed to deliver solid revenue growth in the second quarter despite COVID-19 headwinds.
Is This Under-the-Radar Medical Devices Stock a Buy?
Kody Kester|Nov 3, 2021
The medical devices company beat analyst expectations in the first quarter of its new fiscal year. Could it be a buy?
After Beating Estimates, Is This Little-Known Medical Device Company a Buy?
Kody Kester|Jul 18, 2021
AngioDynamics exceeded analyst expectations on revenue in Q4 2021, but does that make it worth buying?
